Immunology, Microbiology, and Inflammatory Bowel Diseases Section: Gordon R. Greenberg, MD Gordon Greenberg completed medical school and his internship at the University of Calgary (Alberta, Canada). He undertook his internal medicine training and his gastroenterology fellowship at the University of Toronto in Canada, and then completed a research fellowship in Gastrointestinal Endocrinology at the Royal Postgraduate Medical School in London, England. In 1979, he joined the Department of Medicine at the University of Toronto, and rose through the ranks to being crossappointed as a full Professor in the Departments of Medicine and Physiology by 1992. Dr Greenberg was a dedicated clinician scientist who was highly committed to research and was inspirational to his colleagues and trainees. He served as a role model for researchers and clinicians who admired his dedication to both scientific inquiry and patient care. Trained as a classic physiologist, Dr Greenberg made many contributions to understanding neuroendocrine control of gut function, however, his true love was clinical research of inflammatory bowel disease (IBD). He pioneered early research into nutritional support in IBD patients, then showed that the Canadian IBD community could collaborate successfully to conduct large-scale clinical trials with his early randomized controlled trial of budesonide for the treatment of Crohn's disease. More recently, his interest was in the pharmacokinetics of tumor necrosis factor antagonists in IBD, and he laid the foundation for research into therapeutic drug monitoring. Dr Greenberg has published extensively in the medical literature, lectured nationally and internationally, and his presence is dearly missed in the IBD community. 
